Open Access

Right atrial tumor embolism from thoracic chondrosarcoma: A case report

  • Authors:
    • Liyuan Lv
    • Xueqian Wang
    • Ying Zhang
  • View Affiliations

  • Published online on: September 16, 2015     https://doi.org/10.3892/ol.2015.3713
  • Pages: 2807-2811
  • Copyright: © Lv et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Chondrosarcoma accounts for ~15% of all primary malignant bone tumors. Chondrosarcoma of the spine is rare, while intra-atrial tumor embolisms as a result of chondrosarcoma are extremely rare. In the present study, the case of a 70‑year‑old male with thoracic chondrosarcoma, who presented with a fever and exertional dyspnea, is reported. Following anti‑infection treatment with cefoperazone sodium and sulbactam sodium, the patient developed shock and a mass was identified in the right atrium by echocardiogram. The patient subsequently developed acute circular breathing failure and succumbed to the disease. To the best of our knowledge, this is the first case of thoracic chondrosarcoma with a tumor embolism in the right atrium to be reported in the literature.

Introduction

Chondrosarcomas are the second most common type of bone malignancy, worldwide (1). Spine chondrosarcoma account for <10% of all chondrosarcomas (2,3) and the majority are located in the thoracic spine (1,3,4). Diagnosis is based on computed tomography and magnetic resonance imaging, however, pathological diagnosis based on needle biopsies or lesion resection is the gold standard criteria for diagnosis (5). Surgical resection is the most effective treatment strategy (2,3,6), as these tumors are relatively resistant to chemotherapy and radiotherapy (79). However, chondrosarcoma of the spine is associated with a poor prognosis; previous studies determined a 5-year survival rate of 64%. In addition, patients have a median survival time of 6 years following surgery and surgical margins are an important prognostic factor (6,10).

Malignancy is one of the primary risk factors for tumor embolism. Embolism refers to the lodging of an embolus, which may be a blood clot, fat globule, gas bubble or foreign material in the bloodstream. Thromboembolisms are the most common type of tumor embolism, commonly occurring in the pulmonary artery. Tumor embolization is a rare but unique complication of malignancy. Patients with cancer have an increased risk of developing embolism due to tumor- and treatment-mediated hypercoagulability (1113). In an analysis oncology outpatient cohort at Dana-Farber Cancer Institute (Boston, MA, USA), CNS, pancreatic, upper gastrointestinal and lung/pleural malignancies were associated with a significantly higher risk of pulmonary embolism than other malignancies, whereas hematological and breast malignancies had a significantly lower risk of pulmonary embolism (14).

To the best of our knowledge, a right atrial embolism from thoracic chondrosarcoma has not been reported previously. In the present study, the case of an adult male with thoracic chondrosarcoma who succumbed as a result of a right atrial embolism is reported. Written informed consent was obtained from the patient's family.

Case report

A 70-year-old male, who was previously diagnosed with thoracic chondrosarcoma in 2008, presented to Guang'anmen Hospital (Beijing, China) on May 7, 2012 with a fever and exertional dyspnea that had persisted for two weeks. The patient had previously received multimodality therapy for the treatment of local recurrence, osseous metastasis and pulmonary metastasis, which included surgical treatment of recurrent lesions, the placement of an artificial vertebral body, radiotherapy, biological therapy with interleukin-2, administration of bisphosphonates for the treatment of bone metastasis and traditional Chinese medicine (TCM) therapy, as follows. The patient underwent T5 vertebral resection, replacement and posterior fixation for treatment of a thoracic neoplasm at Peking University People's Hospital (Beijing, China) on December 9, 2008. A postoperative pathological diagnosis was chondrosarcoma was determined. The patient subsequently underwent thoracic mass fixation and artificial vertebral body implantation due to local recurrence on June 29, 2011. Chest computed tomography on August 30, 2011 suggested T5-7 vertebral bodies, bone metastases in the adjacent ribs and a mass surrounding the vertebral bodies. Therefore, the patient underwent T5 extrapyramidal radiotherapy (6 MV X-rays at 95% planning target volume administered in 20 fractions of 40 Gy (2 Gy/fraction)] at Peking University Third Hospital (Beijing, China) between September 5, 2011 and October 7, 2011. Later, the patient received interleukin-II therapy (1×106 IU three times a week). Chest computed tomography performed at Peking University Third Hospital on January 13, 2012, suggested bilateral pulmonary nodules. Thus, the patient received additional interleukin-II therapy (1×106 IU five times a week). In April 2012, chest computed tomography suggested progress of the bilateral pulmonary nodules, a mass surrounding vertebral bodies and bone metastases. Consequently, the patient received TCM therapy [20 ml cinobufotalin injection plus 250 ml 0.9% normal saline (NS) intravenously (i.v.) drip daily for 13 days, followed by 20 ml compound Kushen injection plus 250 ml 0.9% NS i.v. drip daily for 13 days] in Guang'anmen Hospital between May 23 and June 5, 2012. On presentation to Guang'anmen Hospital, the patient reported mild shortness of breath and a fever. Initial blood tests, performed on June 7, 2012, revealed leukocytosis with neutrophilia [white blood cell, 9.15×109/l (normal range, 4–10×109/l); neutrophil count, 77.1% (normal range, 51–75%); lymphocyte count, 15.3% (normal range, 20–40%)]. In addition, Klebsiella pneumoniae was identified in bacterial culture of the sputum. The patient was diagnosed with a lung infection and subsequently received anti-infection treatment (cefoperazone sodium and sulbactam sodium, 3 g every 12 h for 12 days) between June 7 and 31, 2012. Following three days of treatment, the fever had gone and the blood tests results were within the normal ranges. However, three weeks later, the patient's breathing suddenly deteriorated and shock developed. The blood pressure decreased to 75/35 mmHg (normal range, 120/80–140/90 mmHg), and a cardiovascular examination revealed tachycardia and systolic blowing murmurs. In addition, diastolic rumbling noises were heard in the auscultatory mitral area. Electrocardiogram (ECG) revealed atrial fibrillation, ST segment changes and an SIQIIITIII right bundle branch block (lead I, apparent S waves; lead III, obvious Q and T wave inversion; Fig. 1), which had not been identified on the ECG performed previously following admission (Fig. 2).

Analysis of the arterial blood gas revealed that the partial pressure of O2 was 53 mmHg at room air temperature (normal range, 80–100 mmHg) and that the partial pressure of CO2 was 35.3 mmHg (normal range, 35–45 mmHg). Echocardiography revealed a 5.0×4.5-cm mass in the right atrium (Fig. 3), severe tricuspid regurgitation and severe pulmonary arterial hypertension. Subsequently, anti-shock therapy, including high-flow (8 l/min) oxygen therapy, intravenous fluids and dopamine, were administered. However, the patient's condition continued to deteriorate and the patient succumbed as a result of the atrial embolism.

Discussion

Chondrosarcoma accounts for ~15% of all primary malignant bone tumors (15). Chondrosarcoma of the spine is rare, and the majority of such cases occur in the vertebral body or attachments (6,10,16). Chondrosarcoma of the spine is most frequently identified in the cervical, thoracic and lumbar vertebrae, with occurrence in the thoracic vertebrae being the most common (5); this preponderance may be due to the greater number of thoracic vertebrae (6). Chondrosarcoma is classified into five types, namely, central, peripheral, mesenchymal, differentiated and clear cell chondrosarcoma. The two most common types of chondrosarcoma are central (arising within a bone) and peripheral (arising from the surface of a bone) (17). In contrast to osteosarcoma, chondrosarcoma usually occurs in adulthood (18).

Malignancy is one of the main risk factors for a tumor embolism. A number of previous studies have reported the occurrence of tumor embolisms in patients with chondrosarcoma (1921). A literature search of PubMed for studies published between 1977 and 2013 was conducted using the following keywords: (‘tumour embolism’ [All Fields] OR ‘neoplastic cells, circulating’ [MeSH Terms] OR (‘neoplastic’ [All Fields] AND ‘cells’ [All Fields] AND ‘circulating’ [All Fields]) OR ‘circulating neoplastic cells’ [All Fields] OR (‘tumor’ [All Fields] AND ‘embolism’ [All Fields]) OR (‘tumor embolism’ [All Fields]) AND (‘chondrosarcoma’ [MeSH Terms]) OR ‘chondrosarcoma’ [All Fields]). The search identified 32 studies. Of these, 20 studies were associated with the subject of ‘tumor embolism with chondrosarcoma’ (19,2139), 14 of which were reported with pulmonary tumor embolism and 3 of which exhibited left atrial embolism. However, no previous studies reporting a large tumor embolism to the right atrium were found.

Intra-atrial tumor embolism is an extremely rare manifestation of chondrosarcoma. Three pathways of cardiac involvement exist: Hematogenous spread, direct invasion from neighboring chest tumors or via the pericardial space, and retrograde lymphatic spread (4043). In the present case, we hypothesize that circulating tumor cells migrated to the heart hematogenously, via the superior vena cava, and that subsequently, the tumor emboli reduced the blood flow volume of the heart. The tumor emboli may have attached to the endocardium, causing an intracardiac obstructive mass. A high proportion of patients with tumor embolisms exhibit widespread metastatic disease at the time of presentation. This is consistent for the patient in this case, who exhibited pulmonary metastasis and bone metastases at presentation.

The clinical presentation of embolisms may include non-specific symptoms, such as chest pain, weight loss and dyspnea, or more characteristic symptoms, such as congestive cardiac failure secondary to intracardiac obstructions and embolic events, as observed in the present case. Tumor site, size and tendency to cause an embolism determine the clinical findings. Embolic events must be considered in patients who develop unexplained heart failure or dyspnea. In such patients, echocardiography presents a useful diagnostic step for the detection of cardiac metastasis (44), as it provides information regarding the mobility of the tumor thrombus and the association between the valve and cardiac muscle with respect to the thrombus (45).

Surgery is the main method of treatment for spinal chondrosarcoma (46,47), as the disease is not sensitive to chemotherapy (48). Furthermore, radiation therapy has been found to have no significant effect on the post-operative outcome of patients with chondrosarcoma (10). In the current study, the patient developed shock following the identification of a mass in the right atrium by echocardiography. Surgical embolectomy was not suitable as the patient was in a state of shock with unstable vital signs. In addition, chemotherapy and radiation therapy were not suitable due to the insensitivity of chondrosarcoma to such treatments. Thus, a high level of awareness is required to establish the diagnosis of an intra-atrial tumor embolism. Embolisms as a result of this disease may also lead to arrhythmias and heart failure. As symptoms may mimic other cardiac conditions, the possibility of an intra-atrial tumor embolism must be considered in order to provide timely treatment.

In conclusion, chondrosarcoma is a tumor that rarely extends to involve the right atrium. To the best of our knowledge, based on the literature search conducted, this is the first case of thoracic chondrosarcoma with a right atrial tumor embolism to be reported in the literature. The patient exhibited poor prognosis due to a number of complications, including pulmonary embolism. The findings of this study may increase awareness with regard to this rare tumor, leading to improved clinical treatment of chondrosarcoma.

References

1 

NCCN Clinical Practice Guidelines in Oncology. Bone Cancer. Version 1. 2015.National Comprehensive Cancer Network. 1–83. 2014.

2 

Sundaresan N, Rosen G and Boriani S: Primary maligant tumors of the spine. Orthop Clin North Am. 40:21–36. 2009. View Article : Google Scholar : PubMed/NCBI

3 

Knoeller SM, Uhl M, Gahr N, Adler CP and Herget GW: Differential diagnosis of primary malignant bone tumors in the spine and sacrum. The radiological and clinical spectrum: Minireview. Neoplasma. 55:16–22. 2008.PubMed/NCBI

4 

Bergh P, Gunterberg B, Meis-Kindblom JM and Kindblom LG: Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: A center-based study of 69 cases. Cancer. 91:1201–1212. 2001. View Article : Google Scholar : PubMed/NCBI

5 

Lloret I, Server A and Bjerkehagen B: Primary spinal chondrosarcoma: Radiologic findings with pathologic correlation. Acta Radiol. 47:77–84. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Boriani S, De Iure F, Bandiera S, Campanacci L, Biagini R, Di Fiore M, Bandello L, Picci P and Bacchini P: Chondrosarcoma of the mobile spine: Report on 22 cases. Spine. 25:804–812. 2000. View Article : Google Scholar : PubMed/NCBI

7 

Harwood AR, Krajbich JI and Fornasier VL: Radiotherapy of chondrosarcoma of bone. Cancer. 45:2769–2777. 1980. View Article : Google Scholar : PubMed/NCBI

8 

Krochak R, Harwood AR, Cummings BJ and Quirt IC: Results of radical radiation for chondrosarcoma of bone. Radiother Oncol. 1:109–115. 1983. View Article : Google Scholar : PubMed/NCBI

9 

Lee FY, Mankin HJ, Fondren G, Gebhardt MC, Springfield DS, Rosenberg AE and Jennings LC: Chondrosarcoma of bone: An assessment of outcome. J Bone Joint Surg Am. 81:326–338. 1999.PubMed/NCBI

10 

York JE, Berk RH, Fuller GN, Rao JS, Abi-Said D, Wildrick DM and Gokaslan ZL: Chondrosarcoma of the spine: 1954 to 1997. J Neurosurg. 90(Suppl): 73–78. 1999.PubMed/NCBI

11 

Khorana AA: Venous thromboembolism and prognosis in cancer. Thromb Res. 125:490–493. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM and Melton LJ III: Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Arch Intern Med. 160:809–815. 2000. View Article : Google Scholar : PubMed/NCBI

13 

Horsted F, West J and Grainge MJ: Risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis. PLoS Med. 9:e10012752012. View Article : Google Scholar : PubMed/NCBI

14 

Shinagare AB, Guo M, Hatabu H, Krajewski KM, Andriole K, Van den Abbeele AD, DiPiro PJ and Nishino M: Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center. Cancer. 117:3860–3866. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Lee DH, Jung SH, Yoon TM, Lee JK, Joo YE and Lim SC: Low grade chondrosarcoma of the nasal septum. World J Clin Cases. 1:64–66. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Camins MB, Duncan AW, Smith J and Marcove RC: Chondrosarcoma of the spine. Spine (Phila Pa 1976). 3:202–209. 1978. View Article : Google Scholar : PubMed/NCBI

17 

Matanić D, Kukuljan M, Grgurević E, Miletić B, Flego V and Muhvić D: Central type of chondrosarcoma with a fulminant course-a case report. Coll Antropol. 36:1037–1040. 2012.PubMed/NCBI

18 

Mahajan AM, Ganvir S, Hazarey V and Mahajan MC: Chondrosarcoma of the maxilla: A case report and review of literature. J Oral Maxillofac Pathol. 17:269–273. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Hayashida K, Nishimura T, Uehara T, Naito H, Takamiya M, Kozuka T, Sakakibara H, Imakita M, Yutani C and Hamada T: A case of pulmonary tumor-embolism from chondrosarcoma of the lower extremity. Kaku Igaku. 22:101–106. 1985.(In Japanese). PubMed/NCBI

20 

Leung DY, Seah PW, Lee LC, Cranney GB and Walsh WF: Embolic chondrosarcoma: An unusual cause of pulmonary embolism. Am Heart J. 126:732–734. 1993. View Article : Google Scholar : PubMed/NCBI

21 

Yoshida K, Miyashita N, Nakajima M, Niki Y and Matsushima T: A case of sternal chondrosarcoma with multiple pulmonary embolisms. Nihon Kokyuki Gakkai Zasshi. 40:166–170. 2002.(In Japanese). View Article : Google Scholar : PubMed/NCBI

22 

Morgan JA and Paone G: Chondrosarcoma presenting as a saddle tumor pulmonary embolism. J Card Surg. 28:436–438. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Schleger S, Weingartner JS, Costi M and Eichinger WB: A primary pulmonary artery chondrosarcoma manifesting as acute pulmonary embolism. Ann Thorac Surg. 94:1731–1733. 2012. View Article : Google Scholar : PubMed/NCBI

24 

Kawaguchi T, Yamanouchi Y, Numa Y, Sakurai Y, Yamahara T, Seno T, Shikata N, Asai A and Kawamoto K: A case of metastatic brain tumor causing multifocal cerebral embolism. Brain Tumor Pathol. 29:63–67. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Chandrasekharan R, Bhagavaldas MC and Mathew AJ: Chondrosarcoma presenting as dyspnea in a 19-year-old man: A case report. J Med Case Rep. 15:1502011. View Article : Google Scholar

26 

Oizumi H, Tanaka R, Shimura H, Sasaki K, Koike H, Hattori N and Tanaka S: A case of cerebral embolism with metastatic chondrosarcoma in the left atrium. J Stroke Cerebrovasc Dis. 20:79–81. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Clark N, Goldenkranz RJ, Maeuser H, Brener BJ, Brief DK, Huston J, Hertz S, Omeish E, Manicone J, Aueron F, et al: Chondrosarcoma of the aorta: A rare source of bowel and lower extremity emboli. J Vasc Surg. 28:939–943. 1998. View Article : Google Scholar : PubMed/NCBI

28 

Yutani C, Imakita M, Ishibashi-Ueda H, Katsuragi M, Yoshioka T and Kunieda T: Pulmonary hypertension due to tumor emboli: A report of three autopsy cases with morphological correlations to radiological findings. Acta Pathol Jpn. 43:135–141. 1993.PubMed/NCBI

29 

Giuliano CT, Kauffman WM, Haller JO, Fletcher BD and Rao SP: Inferior vena cava-right atrial tumor thrombus in malignant pelvic bone tumors in children. Pediatr Radiol. 22:206–208. 1992. View Article : Google Scholar : PubMed/NCBI

30 

Ninomiya M, Nakanishi S, Mitsuda H, Egawa H and Okuhara T: A case of chondrosarcoma of femur forming tumor embolism in the left heart atrium. Nihon Naika Gakkai Zasshi. 80:270–271. 1991.(In Japanese). View Article : Google Scholar : PubMed/NCBI

31 

Tiszlavicz L, Nyirádi L and Ormos J: Fatal chondrosarcoma tumor-embolism. Morphol Igazsagugyi Orv Sz. 27:211–218. 1987.(In Hungarian). PubMed/NCBI

32 

Cohen DE, Mora C and Keefe DL: Echocardiographic findings of metastatic chondrosarcoma involving the left atrium. Am Heart J. 111:993–996. 1986. View Article : Google Scholar : PubMed/NCBI

33 

Boland TW, Winga ER and Kalfayan B: Chondrosarcoma: A case report with left atrial involvement and systemic embolization. J Thorac Cardiovasc Surg. 74:268–272. 1977.PubMed/NCBI

34 

Woodring JH, Bognar B and van Wyk CS: Metastatic chondrosarcoma to the lung with extension into the left atrium via invasion of the pulmonary veins: Presentation as embolic cerebral infarction. Clin Imaging. 26:338–341. 2002. View Article : Google Scholar : PubMed/NCBI

35 

Mangiapan G, Parrot A, Antoine M and Mayaud C: Pulmonary artery hypertension due to tumor micro-embolism. Rev Mal Respir. 12:62–65. 1995.(In French). PubMed/NCBI

36 

Shepard JA, Moore EH, Templeton PA and McLoud TC: Pulmonary intravascular tumor emboli: Dilated and beaded peripheral pulmonary arteries at CT. Radiology. 187:797–801. 1993. View Article : Google Scholar : PubMed/NCBI

37 

Miyawaki F, Matsumoto H, Takayama Y and Asano K: Surgical treatment of transcardiac expansion of ingrowing chondrosarcoma. Kyobu Geka. 36:632–635. 1983.(In Japanese). PubMed/NCBI

38 

Scott AD, Crane P and Staunton MD: Chondrosarcoma - local recurrence and systemic embolization. JR Soc Med. 83:48–49. 1990.

39 

Hayashida K, Nishimura T, Uehara T, Naito H, Takamiya M, Nakajima N and Kozuka T: Cor pulmonale due to embolization of metastatic chondrosarcoma. Heart Vessels. 3:218–222. 1987. View Article : Google Scholar : PubMed/NCBI

40 

Mahdi H, Swensen RE, Hanna R, Kumar S, Ali-Fehmi R, Semaan A, Tamimi H, Morris RT and Munkarah AR: Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary. Br J Cancer. 105:493–497. 2011. View Article : Google Scholar : PubMed/NCBI

41 

Reynen K, Köckeritz U and Strasser RH: Metastases to the heart. Ann Oncol. 2:375–381. 2004. View Article : Google Scholar

42 

Butany J, Nair V, Naseemuddin A, Nair GM, Catton C and Yau T: Cardiac tumours: Diagnosis and management. Lancet Oncol. 6:219–228. 2005. View Article : Google Scholar : PubMed/NCBI

43 

Neragi-Miandoab S, Kim J and Vlahakes GJ: Malignant tumours of the heart: A review of tumour type, diagnosis and therapy. Clin Oncol (R Coll Radiol). 19:748–756. 2007. View Article : Google Scholar : PubMed/NCBI

44 

Tse HF, Lau CP, Lau YK and Lai CL: Transesophageal echocardiography in the detection of inferior vena cava and cardiac metastasis in hepatocellular carcinoma. Clin Cardiol. 19:211–213. 1996. View Article : Google Scholar : PubMed/NCBI

45 

Yoshitomi Y, Kojima S, Sugi T, Matsumoto Y, Yano M, Ozeki Y and Kuramochi M: Echocardiography of a right atrial mass in hepatocellular carcinoma. Heart Vessels. 13:45–48. 1998. View Article : Google Scholar : PubMed/NCBI

46 

Weber KL: What's new in musculoskeletal oncology. J Bone Joint Surg Am. 87:1400–1410. 2005. View Article : Google Scholar : PubMed/NCBI

47 

Pring ME, Weber KL, Unni KK and Sim FH: Chondrosarcoma of the pelvis. J Bone Joint Surg Am. 83:1630–1642. 2001.PubMed/NCBI

48 

Dickey ID, Rose PS, Fuchs B, Wold LE, Okuno SH, Sim FH and Scully SP: Dedifferentiated chondrosarcoma: The role of chemotherapy with updated outcomes. J Bone Joint Surg Am. 86:2412–2418. 2004.PubMed/NCBI

Related Articles

Journal Cover

November-2015
Volume 10 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lv L, Wang X and Zhang Y: Right atrial tumor embolism from thoracic chondrosarcoma: A case report. Oncol Lett 10: 2807-2811, 2015
APA
Lv, L., Wang, X., & Zhang, Y. (2015). Right atrial tumor embolism from thoracic chondrosarcoma: A case report. Oncology Letters, 10, 2807-2811. https://doi.org/10.3892/ol.2015.3713
MLA
Lv, L., Wang, X., Zhang, Y."Right atrial tumor embolism from thoracic chondrosarcoma: A case report". Oncology Letters 10.5 (2015): 2807-2811.
Chicago
Lv, L., Wang, X., Zhang, Y."Right atrial tumor embolism from thoracic chondrosarcoma: A case report". Oncology Letters 10, no. 5 (2015): 2807-2811. https://doi.org/10.3892/ol.2015.3713